Browsing Category
Healthcare Industry News
2470 posts
Celltrion’s Eydenzelt gets FDA nod — Is Eylea finally facing a real biosimilar rival?
Find out how Celltrion’s FDA-approved Eydenzelt is set to challenge Eylea and reshape the biosimilar landscape for retinal diseases in 2025.
OS Therapies eyes global approvals for OST-HER2 after breakthrough osteosarcoma vaccine trial
OS Therapies’ OST-HER2 cancer vaccine shows strong survival gains in Phase IIb osteosarcoma trial—discover what comes next for global approval.
Inside the CDC purge: Why mass firings in America’s top health agency could reshape public safety
Mass firings at CDC deepen U.S. shutdown chaos—see how health surveillance, global response, and disease defense face unprecedented disruption.
Why Johnson & Johnson says Tutanota’s mini-tender offer could put shareholders at risk
Johnson & Johnson (NYSE: JNJ) urges investors to reject Tutanota’s mini-tender offer—find out why the bid poses risks, what it signals for governance, and how markets reacted.
Zoetis (NYSE: ZTS) gains EMA panel endorsement for Lenivia — Could this reshape the €10bn companion-animal market?
Zoetis (NYSE: ZTS) earns EMA panel endorsement for Lenivia, a long-acting antibody injection for canine osteoarthritis pain. Find out what this means for investors and the veterinary industry.
ZimVie investors back $19 a share ARCHIMED deal, setting stage for major medtech shake-up
Find out how ZimVie’s shareholders approved a $19-per-share ARCHIMED acquisition and what it means for medtech investors and M&A sentiment.
Healthcare Triangle posts $34m acquisition plan and $20m Ezovion revenue — signaling aggressive expansion strategy
Find out how Healthcare Triangle is betting big on scale with a $34M acquisition plan and $20M processed revenue milestone on its Ezovion platform.
How Haleon’s Salesforce alliance could transform global consumer health through AI and data cloud integration
Find out how Haleon plc (LSE/NYSE: HLN) is using Salesforce’s Agentforce and Life Sciences Cloud to transform pharmacy engagement and boost AI-driven growth.
Turn Therapeutics expands its float with 7 million shares up for sale — should retail investors be cautious?
Turn Therapeutics (NASDAQ: TTRX) registers 7 million shares for resale by insiders post-direct listing. Learn how this impacts investors, liquidity, and stock sentiment.
UnitedHealth Group expands in Massachusetts: Can Optum’s care empire win over regulators and patients?
UnitedHealth Group’s Massachusetts acquisition tests whether Optum’s data-driven healthcare empire can scale without losing patient trust or facing regulator pushback.